Birmingham Women’s and Children’s NHS Foundation Trust
109 capabilities
Verified Oct 2026
One of 2,018 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Birmingham Women’s Hospital, Mindelsohn Way, Edgbaston
Edgbaston B15 2TG , United Kingdom
Edgbaston B15 2TG , United Kingdom
Accreditation
Active
UKAS
10259
nhs.net
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
10259
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDFOther locations
Test Capabilities (109)
| Standard Reference | Description | Category |
|---|---|---|
| Mycobacterium Tuberculosis | Mycobacterium tuberculosis | Food Safety Testing |
| Leucocytes | Leucocytes: | 8 Colours | Hematology |
| - PT, INR - APTT | - PT, INR - APTT | Other |
| 1. Fibrinogen | 1. Fibrinogen | Other |
| A Rh D Negative | A Rh D negative | Other |
| AB Rh D Negative | AB Rh D negative | Other |
| AB Rh D Positive | AB Rh D positive | Other |
| Acid Mucins | Acid Mucins | Other |
| Adenocarcinoma vs malignant mesothelioma | Adenocarcinoma vs malignant mesothelioma | Other |
| Adenocarcinoma – ovarian vs colorectal | Adenocarcinoma – ovarian vs colorectal | Other |
| Adenocarcinoma, squamous cell carcinoma | Adenocarcinoma, squamous cell carcinoma | Other |
| Andrological examination activities for the purposes of clinical diagnosis | Andrological examination activities for the purposes of clinical diagnosis | Other |
| Antibody used to detect normal or loss of MSH2 expression | Antibody used to detect normal or loss of MSH2 expression | Other |
| Antibody used to detect normal or loss of MSH6 expression | Antibody used to detect normal or loss of MSH6 expression | Other |
| Antigen Phenotyping: - Rh and K C E c e K | Antigen phenotyping : | Using Grifols Eflexis analyser and | Other |
| B Rh D Positive | B Rh D positive | Other |
| B RhD Negative | B RhD Negative | Other |
| Basement membrane protein in muscle | Basement membrane protein in muscle | Other |
| Beta Amyloid in brain tissue | Beta Amyloid in brain tissue | Other |
| Blood Group by detection and identification of antigens: A D Positive | Blood Group by detection and identification of antigens: A Rh D Positive | Other |
| Blood Transfusion Examinations to assist in clinical investigations | Blood Transfusion examinations to assist in clinical investigations | Other |
| Breast carcinoma (prinary & metastatic) | Breast carcinoma (prinary & metastatic) | Other |
| Breast carcinoma and metastatic tumours | Breast carcinoma and metastatic tumours | Other |
| Cancer cells (including neuroendocrine tumor) of colorectal origin | Cancer cells (including neuroendocrine tumor) of colorectal origin | Other |
| Cases of secretory carcinoma and congenital fibrosarcoma. Pan-TRK IHC can help determine whether translation occurs for novel NTRK rearrangements | Cases of secretory carcinoma and congenital fibrosarcoma. Pan-TRK IHC can help determine whether translation occurs for novel NTRK rearrangements | Other |
| Cellular Pathology examination activities for the purposes of clinical diagnosis: Identification of cellular or tissue constituents (antigens) by means of antigen antibody interactions | Cellular Pathology examination activities for the purposes of clinical diagnosis: Identification of nuclei, cell cytoplasm and most connective tissues in cells and tissues | Other |
| Clear cell carcinoma | Clear cell carcinoma | Other |
| Coagulation examination activities for the purpose of clinical diagnosis | Coagulation examination activities for the purpose of clinical diagnosis | Other |
| Collagen, fibrin & muscle | Collagen, fibrin & muscle | Other |
| Compatibility testing of patients’ plasma with donor cells | Compatibility testing of patients’ plasma with donor cells | Other |
| Cytological assessment and interpretation/diagnosis | Cytological assessment and interpretation/diagnosis | Other |
| Detection of haemoglobin S (Hb-S) | Detection of haemoglobin S (Hb-S) | Other |
| Differentiation between benign and malignant liver diseases | Differentiation between benign and malignant liver diseases | Other |
| Direct Antiglobulin TEST (DAT) | Direct Antiglobulin Test (DAT): Detection of antibodies adsorbed on the red cell membrane | Other |
| Elastic fibres, collagen & muscle | Elastic fibres, collagen & muscle | Other |
| Endothelial tumours | Endothelial tumours | Other |
| Expressed in the female genital tract and in epithelial cells of endo cervix and endometrium | Expressed in the female genital tract and in epithelial cells of endo cervix and endometrium | Other |
| Expression of ER containing cells | Expression of ER containing cells | Other |
| Expression of PGR containing cells | Expression of PGR containing cells | Other |
| Ferric Iron | Ferric iron | Other |
| Fertility Testing: Semen pH | Fertility testing: Volume pH | Other |
| Full Blood Count (FBC) analysis of the following parameters: Haemaglobin | Full Blood Count (FBC) analysis of the following parameters: WBC RBC HGB HCT MCV MCH MCHC RDW-CV PLT NEUT LYMPH MONO EOS BASO Reticulocyte count | Other |
| Fungi, neutral mucins /glycogen | Fungi, neutral mucins /glycogen | Other |
| Gastric neoplasms | Gastric neoplasms | Other |
| Glandular and transitional epithelia and neoplasia of type | Glandular and transitional epithelia and neoplasia of type | Other |
| Glucose 6 Phosphate Dehydrogenase (G6PD) screen | Glucose 6 Phosphate Dehydrogenase (G6PD) screen | Other |
| Gram positive & negative bacteria | Gram positive & negative bacteria | Other |
| Granulosa cell tumours | Granulosa cell tumours | Other |
| HPV related high grade cervical intraepithelial squamous neoplasia and glandular neoplasia | HPV related high grade cervical intraepithelial squamous neoplasia and glandular neoplasia | Other |
| Haematology examinations to assist in clinical investigations | Haematology examinations to assist in clinical investigations | Other |
| Haemoglobinopathy screening for: - α and β thalassemia and abnormal haemoglobins - Determination of HbA2, HbF and HbS levels | Haemoglobinopathy screening for: - α and β thalassemia and abnormal haemoglobins - Determination of HbA2, HbF and HbS levels | Other |
| High grade serous carcinomas of the ovary | High grade serous carcinomas of the ovary | Other |
| Identification of antibodies to: - Rh (C, D, E,c, e Cw); - Kell (K k Kpa Kpb Jsa Jsb); - Duffy (Fya Fyb); - Kidd (Jka Jkb); - P1; - MNS (M N S s); - Lutheran (Lua and Lub) - Lea and Leb | Identification of antibodies to: - Rh (C, D, E,c, e Cw); - Kell (K k Kpa Kpb Jsa Jsb); - Duffy (Fya Fyb); - Kidd (Jka Jkb); - P1; - MNS (M N S s); - Lutheran (Lua and Lub) - Lea and Leb | Other |
| Identification of cellular or tissue constituents (antigens) by means of antigen antibody interactions | Identification of cellular or tissue constituents (antigens) by means of antigen antibody interactions | Other |
| Identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (cyclin D1 negative) | Identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (cyclin D1 negative) | Other |
| Kleihauer test for estimation of foeto- maternal haemorrhage: Qualitative screen for the presence of foetal cells | Kleihauer test for estimation of foeto- maternal haemorrhage: Qualitative screen for the presence of foetal cells | Other |
| LMWH Anti Xa assay | LMWH Anti Xa assay | Other |
| Lipids | Lipids | Other |
| Lupus anticoagulant screen and confirmation | Lupus anticoagulant screen and confirmation | Other |
| Malignant melanocytic tumours, Schwannoma | Malignant melanocytic tumours, Schwannoma | Other |
| Malignant melanoma | Malignant melanoma | Other |
| Melanocytes and melanomas | Melanocytes and melanomas | Other |
| Melanocytes, melanomas | Melanocytes, melanomas | Other |
| Mesothelioma, adenocarcinoma, ovarian sex chord stromal tumours | Mesothelioma, adenocarcinoma, ovarian sex chord stromal tumours | Other |
| Mismatch repair gene hMLH1 is a ubiquitous gene encoding the mismatch repair protein (MMR) known as MutL protein homolog 1 (MLH1) | Mismatch repair gene hMLH1 is a ubiquitous gene encoding the mismatch repair protein (MMR) known as MutL protein homolog 1 (MLH1) | Other |
| Molar pregnancy | Molar pregnancy | Other |
| Neuroendocrine cells and neoplasms | Neuroendocrine cells and neoplasms | Other |
| Neuroendocrine cells, NK cells | Neuroendocrine cells, NK cells | Other |
| Neutral & acid mucins / glycogen | Neutral & acid mucins / glycogen | Other |
| Non-neoplastic endometrial stroma | Non-neoplastic endometrial stroma | Other |
| Normal GI epithelia and urothelium and neoplasia of type | Normal GI epithelia and urothelium and neoplasia of type | Other |
| Normal and neoplastic epithelial neoplasia | Normal and neoplastic epithelial neoplasia | Other |
| Normal and neoplastic lung and thyroid cells | Normal and neoplastic lung and thyroid cells | Other |
| Normal, reactive and neoplastic astrocytes | Normal, reactive and neoplastic astrocytes | Other |
| Normal/neoplastic tissue epithelial in origin | Normal/neoplastic tissue epithelial in origin | Other |
| Nucleated red blood cell (NRBC) count | Nucleated red blood cell (NRBC) count | Other |
| O Rh D Negative | O Rh D negative | Other |
| O Rh D Positive | O Rh D positive | Other |
| Parvovirus Infected cells | Parvovirus infected cells | Other |
| Post vasectomy | Post vasectomy: Detection of sperm | Other |
| Primary F/Tube high grade serous Ca, Wilm’s tumour, malignant mesotheliomas Concentrated Antibodies: Germ cell / Yolk sack tumours | Primary F/Tube high grade serous Ca, Wilm’s tumour, malignant mesotheliomas Concentrated Antibodies: Germ cell / Yolk sack tumours | Other |
| Primary cells of mesenchymal origin in normal and neoplastic cells | Primary cells of mesenchymal origin in normal and neoplastic cells | Other |
| Proliferative cells | Proliferative cells | Other |
| Quantitative assessment of volume by calculation from cell count | Quantitative assessment of volume by calculation from cell count | Other |
| Ready to Use Antibodies: Tissue epithelial in origin | Ready to Use Antibodies: Tissue epithelial in origin | Other |
| Reporting of normal and abnormal morphologies | Reporting of normal and abnormal morphologies | Other |
| Reticulin Fibres | Reticulin fibres | Other |
| Rhabdomyosarcomas, leiomyomas, mesotheliomas | Rhabdomyosarcomas, leiomyomas, mesotheliomas | Other |
| SARS-CoV spike and SARS-CoV-2 spike proteins | SARS-CoV spike and SARS-CoV-2 spike proteins | Other |
| Secretory granules of endocrine cells | Secretory granules of endocrine cells | Other |
| Skeletal muscle – Fast type | Skeletal muscle – Fast type | Other |
| Skeletal muscle – Slow type | Skeletal muscle – Slow type | Other |
| Smooth muscle cells, myoepithelial cells, leiomyosarcomas | Smooth muscle cells, myoepithelial cells, leiomyosarcomas | Other |
| Smooth muscle tumours | Smooth muscle tumours | Other |
| Special staining of Histopathology examinations to assist in detection of clinical abnormalities | Special staining of Histopathology examinations to assist in detection of clinical abnormalities | Other |
| Sperm concentration | Sperm concentration | Other |
| Sperm morphology including TZI scoring and round cell count | Sperm morphology including TZI scoring and round cell count | Other |
| Sperm motility | Sperm motility | Other |
| Sperm vitality | Sperm vitality | Other |
| Squamous differentiation in poorly differentiated carcinoma | Squamous differentiation in poorly differentiated carcinoma | Other |
| Squamous epithelium and Neoplasms of type | Squamous epithelium and neoplasms of type | Other |
| Stem cells, melanocytes, mast cells, germ cells | Stem cells, melanocytes, mast cells, germ cells | Other |
| Surface of GI cells, colon carcinoma | Surface of GI cells, colon carcinoma | Other |
| T-cells, NK cells, Thymocytes | T-cells, NK cells, Thymocytes | Other |
| To demonstrate Placental Alkaline phosphatase in the cells | To demonstrate Placental Alkaline phosphatase in the cells | Other |
| Tumor cell nuclei of rhabdomyosarcomas | Tumor cell nuclei of rhabdomyosarcomas | Other |
| Tumour cells in GIT carcinomas | Tumour cells in GIT carcinomas | Other |
| Vascular & lymphatic tumours | Vascular & lymphatic tumours | Other |
| Fungi | Fungi | Sterility Testing |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.